Ardian launches sale of German pharma firm Riemser -sources

From Reuters - March 14, 2018

FRANKFURT (Reuters) - Buyout group Ardian has launched the sale of German healthcare firm Riemser Pharma, which may fetch a valuation of more than 400 million euros ($495 million), people close to the matter said.

Ardian is working with Rothschild and Jefferies on the sale and has approached healthcare groups such as Stada (STAGn.DE), Mylan (MYL.O) and Shanghai Pharma (601607.SS) as potential buyers, as well as private equity investors like Nordic Capital, Montagu, Charterhouse, IK and Fosun, they said.

First-round bids were due this week, they said.

Ardian and the banks declined to comment.

Riemser is expected to report 40 million euros in adjusted earnings before interest, tax, depreciation and amortization this year on sales of 120 million euros.


Continue reading at Reuters »